| Biotechnology feed | All feeds
If you'd like to purchase this article, it's only $3.00.
Retinitis Pigmentosa Results... NewsRX: Jun 9 2009 6:36PM Matching: retinitis pigmentosa Find similar documents
today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis ... Pharmacy Choice: May 31 2009 4:04PM Matching: retinitis pigmentosa Find similar documents
announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP).
RP is a slowly developing condition that... Medical News Today: May 29 2009 8:22AM Matching: retinitis pigmentosa Find similar documents
today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). BioSpace: May 28 2009 6:25PM Matching: retinitis pigmentosa Find similar documents
today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). KSLA: May 28 2009 3:09PM Matching: retinitis pigmentosa Find similar documents
today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). Pharma Live: May 28 2009 1:34PM Matching: retinitis pigmentosa Find similar documents
(Logo: http://www.newscom.com/cgi-bin/prnh/20090528/NE23594LOGO ) In both studies, there was a statistically significant (p< 0.001 for the high dose group in each study), dose-dependent increase in retinal thickness... Genetic Engineering News: May 28 2009 1:21PM Matching: retinitis pigmentosa Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
